![Mitchell Glass](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 48 750 $ in data 30/06/2026
Mitchell Glass is currently Chief Executive Officer & Director at Chronic Airway Therapeutics Pty Ltd., Chairman at Accolade Pharma LLC, Director at Orphagenix, Inc., Director at Avatar Biotechnologies LLC, and Director & Chief Medical Officer at Q.
Former roles include Chief Executive Officer at Aqumen Biopharmaceuticals KK, Chief Executive Officer at Aqumen Biopharmaceuticals NA, Inc., Director & Vice President at GlaxoSmithKline LLC, Executive Director & Chief Medical Officer at Invion Ltd., Chief Medical Officer & VP-Regulatory Affairs at AtheroGenics, Inc., Principal at the University of Pennsylvania, Chief Scientific Officer at University City Science Center, Principal at AstraZeneca, Inc., Principal at Inverseon, Inc., and Chief Medical Officer & EVP-Research & Development at Invion Ltd. Education includes undergraduate and doctorate degrees from The University of Chicago, conferred in 1973 and 1977 respectively.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 13/04/2026 | 12.500 ( 0,16% ) | 48 750 $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| Q/C TECHNOLOGIES, INC. | Direttore Tecnico/Scientifico/R&S | 14/06/2024 |
Accolade Pharma LLC
 Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Presidente | - |
Chronic Airway Therapeutics
 Chronic Airway Therapeutics BiotechnologyHealth Technology Develops treatments for chronic respiratory diseases | Amministratore Delegato | - |
Avatar Biotechnologies LLC | Direttore/Membro del Consiglio | 13/04/2010 |
Orphagenix, Inc. | Direttore/Membro del Consiglio | 13/04/2010 |
| Società | Posizione | Fine |
|---|---|---|
| INVION LIMITED | Direttore Tecnico/Scientifico/R&S | 01/03/2019 |
| INVION LIMITED | Direttore/Membro del Consiglio | 12/02/2019 |
Inverseon, Inc.
 Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Corporate Officer/Principal | 01/09/2012 |
Aqumen Biopharmaceuticals NA, Inc. | Presidente | 02/01/2008 |
| ░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Orphagenix, Inc. | |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University City Science Center
 University City Science Center Investment Trusts/Mutual FundsMiscellaneous Provides physical space, resources and other support to the community | Miscellaneous |
AstraZeneca, Inc.
 AstraZeneca, Inc. BiotechnologyHealth Technology Manufactures vaccines | Health Technology |
Aqumen Biopharmaceuticals KK
 Aqumen Biopharmaceuticals KK Pharmaceuticals: MajorHealth Technology Develops and researches therapeutic medicines | Health Technology |
Inverseon, Inc.
Inverseon, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
Aqumen Biopharmaceuticals NA, Inc. | |
Avatar Biotechnologies LLC | |
Invion Ltd.
 Invion Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for chronic lung diseases | Health Technology |
Accolade Pharma LLC
Accolade Pharma LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
MyMD Pharmaceuticals, Inc.
 MyMD Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that engages in the development of drug products to extend healthy lifespan | Health Technology |
Chronic Airway Therapeutics
Chronic Airway Therapeutics BiotechnologyHealth Technology Develops treatments for chronic respiratory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
